CL2023000395A1 - Síntesis de compuestos de quinazolina. - Google Patents
Síntesis de compuestos de quinazolina.Info
- Publication number
- CL2023000395A1 CL2023000395A1 CL2023000395A CL2023000395A CL2023000395A1 CL 2023000395 A1 CL2023000395 A1 CL 2023000395A1 CL 2023000395 A CL2023000395 A CL 2023000395A CL 2023000395 A CL2023000395 A CL 2023000395A CL 2023000395 A1 CL2023000395 A1 CL 2023000395A1
- Authority
- CL
- Chile
- Prior art keywords
- synthesis
- quinazoline compounds
- compounds
- quinazoline
- atropisomeric
- Prior art date
Links
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
En la presente se proporcionan métodos para sintetizar compuestos de quinazolina que comprenden al menos un centro atropisomérico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063064746P | 2020-08-12 | 2020-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2023000395A1 true CL2023000395A1 (es) | 2023-07-28 |
Family
ID=77543703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2023000395A CL2023000395A1 (es) | 2020-08-12 | 2023-02-07 | Síntesis de compuestos de quinazolina. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20220081413A1 (es) |
EP (1) | EP4196470A1 (es) |
JP (1) | JP2023537999A (es) |
KR (1) | KR20230049679A (es) |
CN (1) | CN116057052A (es) |
AR (1) | AR123200A1 (es) |
AU (2) | AU2021325869C1 (es) |
BR (1) | BR112023002591A2 (es) |
CA (1) | CA3191001A1 (es) |
CL (1) | CL2023000395A1 (es) |
CR (1) | CR20230123A (es) |
IL (1) | IL300309A (es) |
MX (1) | MX2023001682A (es) |
PE (1) | PE20230733A1 (es) |
TW (1) | TWI829003B (es) |
WO (1) | WO2022035790A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023150706A1 (en) * | 2022-02-07 | 2023-08-10 | Genentech, Inc. | Solid forms of 1-((s)-4-((r)-7-(6-amino-4-methyl-3- (trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((s)-1- methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3- methylpiperazin-1-yl)prop-2-en-1-one |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010014005A (es) | 2008-06-20 | 2011-02-15 | Genentech Inc | Compuestos de triazolopiridina inhibidores de jak y los metodos. |
CN102686581B (zh) * | 2009-12-21 | 2015-08-26 | 张强 | 喹唑啉衍生物 |
JP2013107855A (ja) * | 2011-11-22 | 2013-06-06 | Mitsubishi Tanabe Pharma Corp | 医薬組成物 |
KR20160076519A (ko) * | 2013-10-10 | 2016-06-30 | 아락세스 파마 엘엘씨 | Kras g12c 억제제 |
US9988357B2 (en) * | 2015-12-09 | 2018-06-05 | Araxes Pharma Llc | Methods for preparation of quinazoline derivatives |
IL282916B1 (en) * | 2018-11-09 | 2024-05-01 | Hoffmann La Roche | United Cyclic Chemical Compounds and Their Uses in the Treatment of RAS-Mediated Disorders |
-
2021
- 2021-08-10 CN CN202180056371.XA patent/CN116057052A/zh active Pending
- 2021-08-10 JP JP2023509849A patent/JP2023537999A/ja active Pending
- 2021-08-10 US US17/398,345 patent/US20220081413A1/en active Pending
- 2021-08-10 MX MX2023001682A patent/MX2023001682A/es unknown
- 2021-08-10 CA CA3191001A patent/CA3191001A1/en active Pending
- 2021-08-10 KR KR1020237007998A patent/KR20230049679A/ko unknown
- 2021-08-10 TW TW110129429A patent/TWI829003B/zh active
- 2021-08-10 PE PE2023000241A patent/PE20230733A1/es unknown
- 2021-08-10 AR ARP210102232A patent/AR123200A1/es unknown
- 2021-08-10 EP EP21762952.6A patent/EP4196470A1/en active Pending
- 2021-08-10 CR CR20230123A patent/CR20230123A/es unknown
- 2021-08-10 AU AU2021325869A patent/AU2021325869C1/en active Active
- 2021-08-10 IL IL300309A patent/IL300309A/en unknown
- 2021-08-10 BR BR112023002591A patent/BR112023002591A2/pt unknown
- 2021-08-10 WO PCT/US2021/045297 patent/WO2022035790A1/en active Application Filing
-
2023
- 2023-02-07 CL CL2023000395A patent/CL2023000395A1/es unknown
-
2024
- 2024-01-12 AU AU2024200220A patent/AU2024200220A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
PE20230733A1 (es) | 2023-05-03 |
KR20230049679A (ko) | 2023-04-13 |
WO2022035790A1 (en) | 2022-02-17 |
TWI829003B (zh) | 2024-01-11 |
IL300309A (en) | 2023-04-01 |
US20220081413A1 (en) | 2022-03-17 |
AU2024200220A1 (en) | 2024-02-01 |
JP2023537999A (ja) | 2023-09-06 |
AU2021325869C1 (en) | 2024-05-30 |
AR123200A1 (es) | 2022-11-09 |
CA3191001A1 (en) | 2022-02-17 |
AU2021325869A1 (en) | 2023-02-23 |
CR20230123A (es) | 2023-04-19 |
CN116057052A (zh) | 2023-05-02 |
EP4196470A1 (en) | 2023-06-21 |
MX2023001682A (es) | 2023-02-22 |
BR112023002591A2 (pt) | 2023-04-04 |
TW202214596A (zh) | 2022-04-16 |
AU2021325869B2 (en) | 2024-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20210080A7 (es) | Triazinas sustituidas como inhibidores de proteína tirosina fosfatasa | |
AR122785A2 (es) | Inhibidores de kras g12c y métodos para su uso | |
DOP2022000082A (es) | Heterociclos bicíclicos como inhibidores de fgfr | |
CL2020001931A1 (es) | Compuestos para el tratamiento de trastornos dependientes de cinasas. | |
CL2023000395A1 (es) | Síntesis de compuestos de quinazolina. | |
BR112023017763A2 (pt) | Inibidores kras g12d | |
CR10600A (es) | Ciclopenta (d) pirimidinas hidroxiladas y metoxiladas como inhibidores de akt proteina quinasa | |
GT200200273A (es) | Moleculas pequeñas para el tratamiento del crecimiento celular anormal | |
BR112022009390A2 (pt) | Síntese melhorada de composto inibidor de kras g12c | |
EA201291246A1 (ru) | Конденсированные бициклические ингибиторы киназы | |
BR112023017661A2 (pt) | Inibidores de kras | |
AR122719A1 (es) | Moléculas agonistas de unión al antígeno cd28 que se dirigen a her2 | |
CL2020001930A1 (es) | Compuestos para el tratamiento de trastornos dependientes de cinasas. | |
BR112022012512A2 (pt) | Método para a preparação de l-glufosinato | |
CO2023006684A2 (es) | Anticuerpos contra sars-cov-2 y usos de los mismos | |
ECSP23051657A (es) | Nuevos compuestos como inhibidor dual del receptor de andrógenos y de la fosfodiesterasa | |
CL2020002217A1 (es) | Uso de alcoxipirazoles como inhibidores de la nitrificación | |
MX2023006606A (es) | Derivados biciclicos. | |
BR112022021899A2 (pt) | Método para a síntese contínua de paracetamol | |
CO2023002375A2 (es) | Anticuerpos contra ilt2 y uso de los mismos | |
CL2020002216A1 (es) | Uso de compuestos de alcoxi pirazol funcionalizados con n como inhibidores de la nitrificación | |
CL2021002011A1 (es) | Procedimiento para la reducción de olor de materiales de carbono en forma de partículas | |
CU20220019A7 (es) | Proteínas de fusión nkg2d | |
CL2023001565A1 (es) | Inhibidores de enzimas | |
EA202192840A1 (ru) | Способ получения соединений карбамоилоксиметилтриазолциклогексиловой кислоты |